FDA Approves New Range of Respiratory Devices
27 January 2016
ASX ANNOUNCEMENT
FDA Approves New Range of Respiratory Devices
Medical Developments International Limited (ASX: MVP) is delighted to announce that it has received approval from the US Food and Drug Administration (FDA) to sell its new range of anti-static respiratory devices in the USA.
The approval represents a significant opportunity to build MDI’s global respiratory business, particularly in the USA. This approval was anticipated and recent marketing efforts means the approval complements a number of Distribution Agreements entered into with North American business partners over the last month. As a consequence, MVP expects to achieve new sales in the near term.
For more information please refer to the following link ASX Announcement_FDA Approves New Range of Respiratory Devices